Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ: MRVI · Real-Time Price · USD

6.51

+0.15 (2.36%)

At close: Jul 14, 2026, 4:00 PM EDT

6.53

+0.02 (0.31%)

Pre-market: Jul 15, 2026, 8:25 AM EDT

MRVI Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	204.73	185.74	259.19	288.95	883	799.24
Revenue Growth (YoY)	-15.35%	-28.34%	-10.30%	-67.28%	10.48%	181.32%
Cost of Revenue	144.76	151.75	150.88	148.74	168.96	140.56
Gross Profit	59.97	33.99	108.31	140.2	714.04	658.68
Selling, General & Admin	134.65	145.12	161.77	151.39	129.26	100.06
Research & Development	16.4	17.4	19.22	17.28	18.37	15.22
Other Operating Expenses	76.98	86.74	162.93	3.18	-7.8	11.25
Total Operating Expenses	228.03	249.26	343.93	171.85	139.83	126.53
Operating Income	-107.31	-215.27	-235.62	-31.65	574.22	554.65
Interest Income	10.08	11.44	27.4	27.73	2.34	-
Interest Expense	-25.96	-26.99	-47.7	-45.89	-20.41	-30.26
Other Non-Operating Income (Expense)	-4.67	-4.15	-5.57	667.55	-4.67	6.38
Total Non-Operating Income (Expense)	-20.55	-19.71	-25.87	649.38	-22.74	-23.88
Pretax Income	-125.8	-234.97	-261.48	617.74	551.47	530.77
Provision for Income Taxes	-4.53	-4.21	-1.86	756.11	60.81	61.52
Net Income	-114.89	-230.76	-259.62	-138.38	490.66	469.25
Minority Interest in Earnings	-49.75	-99.99	-114.78	-19.35	270.46	287.21
Net Income to Common	-65.15	-130.77	-144.85	-119.03	220.21	182.04
Net Income Growth	-	-	-	-	20.97%	104.60%
Shares Outstanding (Basic)	92	144	138	132	255	258
Shares Outstanding (Diluted)	92	144	138	132	255	258
Shares Change (YoY)	-2.12%	4.68%	4.54%	-48.33%	-0.96%	-
EPS (Basic)	-0.71	-0.90	-1.05	-0.90	1.67	1.59
EPS (Diluted)	-0.71	-0.90	-1.05	-0.90	1.67	1.56
EPS Growth	-	-	-	-	7.05%	-33.90%
Free Cash Flow	-27.5	-69.99	-15.05	73.54	519.99	353.72
Free Cash Flow Growth	-	-	-	-85.86%	47.01%	179.00%
Free Cash Flow Per Share	-0.30	-0.48	-0.11	0.56	2.04	1.37
Gross Margin	29.29%	18.30%	41.79%	48.52%	80.87%	82.41%
Operating Margin	-52.41%	-115.89%	-90.91%	-10.95%	65.03%	69.40%
Profit Margin	-56.12%	-124.24%	-100.17%	-47.89%	55.57%	58.71%
FCF Margin	-13.43%	-37.68%	-5.81%	25.45%	58.89%	44.26%
EBITDA	-48.77	-154.79	-178.75	17.13	612.32	588.19
EBITDA Margin	-23.82%	-83.34%	-68.97%	5.93%	69.35%	73.59%
EBIT	-107.31	-215.27	-235.62	-31.65	574.22	554.65
EBIT Margin	-52.41%	-115.89%	-90.91%	-10.95%	65.03%	69.40%
Effective Tax Rate	3.60%	1.79%	0.71%	122.40%	11.03%	11.59%

SEC Filings: 10-K · 10-Q